Iqvia price target raised to $273 from $254 at Stifel

Stifel analyst Shlomo Rosenbaum raised the firm’s price target on Iqvia (IQV) to $273 from $254 and keeps a Buy rating on the shares. The firm came away from recent investor meetings with management with a sense that the sector should continue to recover into 2026, but the pace of the recovery through 2026 remains uncertain, the analyst tells investors in a research note. The firm added that it continues to like Iqvia’s positioning in the market, and recommends investors purchase the shares to participate in the market recovery through the best-in-class player in the space.